111 related articles for article (PubMed ID: 2247438)
1. Two genes encode factors with NF-kappa B- and H2TF1-like DNA-binding properties.
Rustgi AK; Van 't Veer LJ; Bernards R
Proc Natl Acad Sci U S A; 1990 Nov; 87(22):8707-10. PubMed ID: 2247438
[TBL] [Abstract][Full Text] [Related]
2. Two transcription factors, NF-kappa B and H2TF1, interact with a single regulatory sequence in the class I major histocompatibility complex promoter.
Baldwin AS; Sharp PA
Proc Natl Acad Sci U S A; 1988 Feb; 85(3):723-7. PubMed ID: 3422454
[TBL] [Abstract][Full Text] [Related]
3. The role of the p50 and p65 subunits of NF-kappa B in the recognition of cognate sequences.
Urban MB; Baeuerle PA
New Biol; 1991 Mar; 3(3):279-88. PubMed ID: 1878350
[TBL] [Abstract][Full Text] [Related]
4. Alteration of a single nucleotide allows efficient binding of H2TF1/KBF1 to the immunoglobulin kappa enhancer B motif.
Mauxion F; Sen R
Mol Cell Biol; 1989 Aug; 9(8):3548-52. PubMed ID: 2677676
[TBL] [Abstract][Full Text] [Related]
5. Purification of the major histocompatibility complex class I transcription factor H2TF1. The full-length product of the nfkb2 gene.
Potter DA; Larson CJ; Eckes P; Schmid RM; Nabel GJ; Verdine GL; Sharp PA
J Biol Chem; 1993 Sep; 268(25):18882-90. PubMed ID: 8360178
[TBL] [Abstract][Full Text] [Related]
6. The DNA binding subunit of NF-kappa B is identical to factor KBF1 and homologous to the rel oncogene product.
Kieran M; Blank V; Logeat F; Vandekerckhove J; Lottspeich F; Le Bail O; Urban MB; Kourilsky P; Baeuerle PA; Israël A
Cell; 1990 Sep; 62(5):1007-18. PubMed ID: 2203531
[TBL] [Abstract][Full Text] [Related]
7. A multiprotein complex consisting of the cellular coactivator p300, AP-1/ATF, as well as NF-kappaB is responsible for the activation of the mouse major histocompatibility class I (H-2K(b)) enhancer A.
Brockmann D; Pützer BM; Lipinski KS; Schmücker U; Esche H
Gene Expr; 1999; 8(1):1-18. PubMed ID: 10543727
[TBL] [Abstract][Full Text] [Related]
8. Altered binding of regulatory factors to HLA class I enhancer sequence in human tumor cell lines lacking class I antigen expression.
Blanchet O; Bourge JF; Zinszner H; Israel A; Kourilsky P; Dausset J; Degos L; Paul P
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3488-92. PubMed ID: 1565643
[TBL] [Abstract][Full Text] [Related]
9. Molecular cloning of an enhancer binding protein: isolation by screening of an expression library with a recognition site DNA.
Singh H; LeBowitz JH; Baldwin AS; Sharp PA
Cell; 1988 Feb; 52(3):415-23. PubMed ID: 2964277
[TBL] [Abstract][Full Text] [Related]
10. Isolation of a candidate repressor/activator, NF-E1 (YY-1, delta), that binds to the immunoglobulin kappa 3' enhancer and the immunoglobulin heavy-chain mu E1 site.
Park K; Atchison ML
Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9804-8. PubMed ID: 1946405
[TBL] [Abstract][Full Text] [Related]
11. Angiotensinogen gene-inducible enhancer-binding protein 1, a member of a new family of large nuclear proteins that recognize nuclear factor kappa B-binding sites through a zinc finger motif.
Ron D; Brasier AR; Habener JF
Mol Cell Biol; 1991 May; 11(5):2887-95. PubMed ID: 2017183
[TBL] [Abstract][Full Text] [Related]
12. The transcriptional silencer protein NRF: a repressor of NF-kappa B enhancers.
Nourbakhsh M; Hauser H
Immunobiology; 1997 Dec; 198(1-3):65-72. PubMed ID: 9442378
[TBL] [Abstract][Full Text] [Related]
13. Novel zinc chelators with dual activity in the inhibition of the kappa B site-binding proteins HIV-EP1 and NF-kappa B.
Otsuka M; Fujita M; Aoki T; Ishii S; Sugiura Y; Yamamoto T; Inoue J
J Med Chem; 1995 Aug; 38(17):3264-70. PubMed ID: 7650680
[TBL] [Abstract][Full Text] [Related]
14. Iodide suppression of major histocompatibility class I gene expression in thyroid cells involves enhancer A and the transcription factor NF-kappa B.
Taniguchi SI; Shong M; Giuliani C; Napolitano G; Saji M; Montani V; Suzuki K; Singer DS; Kohn LD
Mol Endocrinol; 1998 Jan; 12(1):19-33. PubMed ID: 9440807
[TBL] [Abstract][Full Text] [Related]
15. Molecular cloning and characterization of a novel Rel/NF-kappa B family member displaying structural and functional homology to NF-kappa B p50/p105.
Mercurio F; Didonato J; Rosette C; Karin M
DNA Cell Biol; 1992 Sep; 11(7):523-37. PubMed ID: 1388725
[TBL] [Abstract][Full Text] [Related]
16. Structure and expression of major histocompatibility complex-binding protein 2, a 275-kDa zinc finger protein that binds to an enhancer of major histocompatibility complex class I genes.
van 't Veer LJ; Lutz PM; Isselbacher KJ; Bernards R
Proc Natl Acad Sci U S A; 1992 Oct; 89(19):8971-5. PubMed ID: 1409593
[TBL] [Abstract][Full Text] [Related]
17. Identification and purification of a human immunoglobulin-enhancer-binding protein (NF-kappa B) that activates transcription from a human immunodeficiency virus type 1 promoter in vitro.
Kawakami K; Scheidereit C; Roeder RG
Proc Natl Acad Sci U S A; 1988 Jul; 85(13):4700-4. PubMed ID: 3133660
[TBL] [Abstract][Full Text] [Related]
18. NF-kappa B homodimer binding within the HIV-1 initiator region and interactions with TFII-I.
Montano MA; Kripke K; Norina CD; Achacoso P; Herzenberg LA; Roy AL; Nolan GP
Proc Natl Acad Sci U S A; 1996 Oct; 93(22):12376-81. PubMed ID: 8901589
[TBL] [Abstract][Full Text] [Related]
19. Regulation of 3' IgH enhancers by a common set of factors, including kappa B-binding proteins.
Michaelson JS; Singh M; Snapper CM; Sha WC; Baltimore D; Birshtein BK
J Immunol; 1996 Apr; 156(8):2828-39. PubMed ID: 8609402
[TBL] [Abstract][Full Text] [Related]
20. A large protein containing zinc finger domains binds to related sequence elements in the enhancers of the class I major histocompatibility complex and kappa immunoglobulin genes.
Baldwin AS; LeClair KP; Singh H; Sharp PA
Mol Cell Biol; 1990 Apr; 10(4):1406-14. PubMed ID: 2108316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
